A Literature Review on the Vaccination of COVID-19 in Pregnant and Breastfeeding Women: Effectiveness and Safety

Authors

  • Fitriani Nur Damayanti Midwifery Study Program, Faculty of Nursing and Health, Universitas Muhammadiyah Semarang, Semarang, Indonesia
  • Alfina Aprilia Riafisari Midwifery Study Program, Faculty of Nursing and Health, Universitas Muhammadiyah Semarang, Semarang, Indonesia
  • Ayesha Hendriana Ngestiningrum Department of Midwifery, Politeknik Kesehatan Kemenkes Surabaya, Surabaya, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.6651

Keywords:

COVID-19, Vaccination, Pregnant, Breastfeeding, Women

Abstract

Background: Pregnant women and breastfeeding women who are infected with the COVID-19 virus have a high risk, but pregnant women and women who breastfeed are not included in the initial vaccine trial for coronavirus 19 (COVID-19). There are currently no clinical data on the use of the COVID-19 mRNA vaccine in pregnant and lactating women.

Aim: This study aims to get a picture about nurse’s knowledge, attitude and supervision, and its relationship to the implementation of pain reassessment.

Methods: The method used in this paper is the Literature Review study. The data based used in the source search were Google Scholar, PubMed, JAMA, and AJOG which aimed to collect themes regarding the discussion of COVID-19 Vaccination in Pregnant and Breastfeeding Women. The COVID-19 mRNA vaccine creates immunity in pregnant and lactating women.

Results: IgG immunoglobulin after vaccination in pregnant, lactating and non-pregnant women increased significantly and was stronger than pregnant women who were previously infected with SARS-CoV-2

Conclusion: Pregnant and lactating women have a stronger immune response after being vaccinated than pregnant women who were previously infected with SARS-CoV-2. Immune transfer to neonates occurs through placenta and breast milk, antibodies are formed after vaccination in the third trimester of pregnancy. Immunogenicity and reactogenicity reactions after the vaccine are the same as for nonpregnant women. Therefore, education is needed by health workers to patients about the risks and benefits of vaccines for pregnant and lactating women.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Smith DD, Pippen JL, Adesomo AA, Rood KM, Landon MB, Costantine MM. Exclusion of pregnant women from clinical trials during the Coronavirus disease 2019 pandemic: A review of international registries. Am J Perinatol. 2020;37(8):792-9. https://doi.org/10.1055/s-0040-1712103 PMid:32428965 DOI: https://doi.org/10.1055/s-0040-1712103

Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. COVID-19 vaccine response in pregnant and lactating women: A cohort study. medRxiv. 2021;2021:21253094. https://doi.org/10.1101/2021.03.07.21253094 PMid:33758889 DOI: https://doi.org/10.1101/2021.03.07.21253094

Stafford IA, Parchem JG, Sibai BM. The Coronavirus disease 2019 vaccine in pregnancy: Risks, benefits, and recommendations. Am J Obstet Gynecol. 2021;224(5):484-95. https://doi.org/10.1016/j.ajog.2021.01.022 PMid:33529575 DOI: https://doi.org/10.1016/j.ajog.2021.01.022

Zipursky JS, Greenberg RA, Maxwell C, Bogler T. Pregnancy, breastfeeding and the SARS-CoV-2 vaccine: An ethics-based framework for shared decision-making. CMAJ. 2021;193(9):E312-4. https://doi.org/10.1503/cmaj.202833 PMid:33504561 DOI: https://doi.org/10.1503/cmaj.202833

Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594-9. PMid:32998157 DOI: https://doi.org/10.1038/s41586-020-2814-7

Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2-preliminary report. N Engl J Med. 2020;383(20):1920-31. PMid:32663912

Academy of Breastfeeding Medicine. Considerations for COVID-19 Vaccination in Lactation; 2020. Available from: https://www.bfmed.org/abm-statement-considerations-for-covid-19-vaccination-in-lactation. [Last accessed on 2021 Apr 17]. https://doi.org/10.1089/bfm.2020.29172.abm DOI: https://doi.org/10.1089/bfm.2020.29172.abm

Gill L, Jones CW. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy. Obstet Gynecol. 2021;137(5):894-6. https://doi.org/10.1097/aog.0000000000004367 PMid:33684922 DOI: https://doi.org/10.1097/AOG.0000000000004367

Rasmussen SA, Kelley CF, Horton JP, Jamieson DJ. Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: What obstetricians need to know. Obstet Gynecol. 2021;137(3):408-14. https://doi.org/10.1097/aog.0000000000004290 PMid:33878057 DOI: https://doi.org/10.1097/AOG.0000000000004290

Adhikari EH, Spong CY. COVID-19 vaccination in pregnant and lactating women. JAMA. 2021;325(11):1039-40. https://doi.org/10.1001/jama.2021.1658 PMid:33555297 DOI: https://doi.org/10.1001/jama.2021.1658

Kemenkes RI. Surat Edaran Nomor: HK.02.02/I/368/2021. Indonesia: Kemenkes RI; 2021.

Downloads

Published

2021-08-21

How to Cite

1.
Damayanti FN, Riafisari AA, Ngestiningrum AH. A Literature Review on the Vaccination of COVID-19 in Pregnant and Breastfeeding Women: Effectiveness and Safety. Open Access Maced J Med Sci [Internet]. 2021 Aug. 21 [cited 2024 Apr. 16];9(F):234-7. Available from: https://oamjms.eu/index.php/mjms/article/view/6651

Issue

Section

Narrative Review Article

Categories